{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00180",
      "entity_text" : "tocilizumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Therefore, tocilizumab would be treated as nothing more than a foreign substance, not as a therapeutic agent, and might stimulate systemic inflammation induced by hIL6 as well as a strong immune response.",
  "reading_complete" : "2020-08-04T09:02:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:01:17Z",
  "trigger" : "stimulate",
  "evidence" : [ "tocilizumab would be treated as nothing more than a foreign substance, not as a therapeutic agent, and might stimulate systemic inflammation" ],
  "pmc_id" : "3561642",
  "score" : 0
}